DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tregalizumab
Tregalizumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Biologic Armamentarium in Psoriasis
Immunfarmakológia Immunfarmakológia
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Novel Psoriasis Therapies and Patient Outcomes, Part 2: Biologic Treatments
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Rheumatoid Arthritis: Old and New Approaches Shifting the Treatment Paradigm Laura Runkel Associate Director, Autoimmune/ Inflammation, CNS, Ophthalmology
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
Title of Presentation Arial 50Pt Bold
A61K9/51 (2006.01) — with International Search Report (Art
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Efficacy of Pharmacological Treatment in Rheumatoid Arthritis
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Annrheumdis-2019-216653.Full.Pdf
Top View
14-083 Phrma Arthritis2014 0716.Indd
Analysis of Fcγ Receptor Cross-Linking and Anti-CD4-Specific Monoclonal Antibody Function
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Clinical Development
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Listes De DCI Proposées N'implique Aucune Recommandation En Vue De L'utilisation De La Substance Correspondante En Médecine Ou En Pharmacie
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Recent Advances Show That Abnormal T-Regulatory Cell Function Perpetuates Chronic Inflammatory Arthritis
(INN) for Biological and Biotechnological Substances
Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment
Antibodies[Version 1; Peer Review: 2 Approved]
A Monoclonal Antibody to Target Regulatory T Cells
Cimzia (Certolizumab Pegol) (Rheumatoid Arthritis)
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Older Americans Affecting Diseases Chronic Top
CAPTURE Study 2089
(12) 按照专利合作条约所公布的国际申请w O 2016/050208